SpringerLink
Log in

Do elderly patients have a worse outcome in response to platinum-based therapy for metastatic urothelial cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yancik R (1997) Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 22: 3–9

    CAS  PubMed  Google Scholar 

  2. von der Maase H et al. (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18: 3068–3077

    Article  CAS  Google Scholar 

  3. Balducci L et al. (2000) Cancer in the frail patient. A coming epidemic. Hematol Oncol Clin North Am 14: 235–250, xi

    Article  CAS  Google Scholar 

  4. Repetto L et al. (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20: 494–502

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Fellow, University of Chicago, IL, USA

    Supriya G Mohile

  2. Associate Professor at the University of Chicago, IL, USA

    Walter M Stadler

Authors
  1. Supriya G Mohile
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter M Stadler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Walter M Stadler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

ECOG PERFORMANCE STATUS

A 0 (fully active) to 5 (dead) scoring system to assess the wellbeing of cancer patients and their ability to perform ordinary tasks

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohile, S., Stadler, W. Do elderly patients have a worse outcome in response to platinum-based therapy for metastatic urothelial cancer?. Nat Rev Clin Oncol 2, 392–393 (2005). https://doi.org/10.1038/ncponc0247

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0247

  • Springer Nature Limited

Search

Navigation